Cognitive dysfunction evaluation in multiple sclerosis patients treated with interferon beta-1b: An open-label prospective 1 year study

Israel Medical Association Journal

Volumn 9, Issue 6, 2007, Pages 457-459

  Flechter, Shlomo ^a,c   Vardi, Jacob ^b   Finkelstein, Yoram ^b   Pollak, Lea ^a,c  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b SHAARE ZEDEK MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cognition; Interferon beta 1b; Multiple sclerosis; P300

Indexed keywords

INTERFERON BETA SERINE;

ADULT; ARTICLE; BRAIN FUNCTION; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; DISEASE COURSE; EVENT RELATED POTENTIAL; FEMALE; FOLLOW UP; FRONTAL LOBE; HUMAN; LATENT PERIOD; MALE; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TEST; OPEN STUDY; PARIETAL LOBE; PROSPECTIVE STUDY; QUALITY OF LIFE; RECURRENT DISEASE; STUDENT T TEST; WISCONSIN CARD SORTING TEST;

ACOUSTIC STIMULATION; ADJUVANTS, IMMUNOLOGIC; ADULT; COGNITION; COGNITION DISORDERS; EVOKED POTENTIALS, AUDITORY; FEMALE; FRONTAL LOBE; HUMANS; INTERFERON-BETA; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TESTS; OUTPATIENT CLINICS, HOSPITAL; PARIETAL LOBE; PROSPECTIVE STUDIES; QUALITY OF LIFE; TIME FACTORS; TREATMENT OUTCOME;

EID: 34250800903     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Hamalainen P, Ruutiaine J. Cognitive decline in multiple sclerosis. INT MSJ 1998;6:51-7.
2. Thornton AE, Raz N. Memory impairment in multiple sclerosis: a quantitative review. Neuropsychology 1997;11:357-66.
3. Beaty WW. Memory and "Frontal lobe" dysfunction in multiple sclerosis. J Neurol Sci 1993;115:38-41.
4. Goodin DS, Aminoff MJ. Evaluation of dementia by event related potentials. J Clin Neurophysiol 1992;9:521-5.
5. Kessetring J, Klement U. Cognitive and affective disturbances in multiple sclerosis. J Neurol 2001;248:180-3.
6. Halgren E, Squires NK, Wilson CL, Rohrbaugh JW, Babb TL, Crandall PH. Endogenous potentials generated in the human hippocampal formation and amygdala by infrequent events. Science 1980;210:803-5.
7. Smith ME, Halgren E, Sokolik M, et al. The intracranial topography of the p300 event-related potential elicited during auditory oddball. Electroencephaloyr Clin Neurophysiol 1990;76:235-48.
8. Kessler HR, Cohen RA, Lauer K, et al. The relationship between disability and memory dysfunction in multiple sclerosis. Int J Neuroscience 1992;62:17-31.
9. Kropotov JD, Ponomarev VA. Subcortical neuronal correlates of component P300 in man. Electroencephalogr Clin Neurophysiol 1991;78:40-9.
10. Ranshohoff RM. Management of multiple sclerosis. N Engl J Med 1997;337:1604-11.
11. The INFβ multiple sclerosis study group. Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 1995;45:1277-85.
12. Weinstein A, Schwid SR, Schiffer RB, et al. Neuropsychological status in multiple sclerosis after treatment with glatiramer acetate (Copaxone). Arch Neurol 1999;56:319-24.
13. Rao SM, Hammeku TA, Speech TJ. Wisconsin Card Sorting Test performance in relapsing-remitting and chronic-progressive multiple sclerosis. J Consult Clin Psychol 1987;55:263-5.
14. Anderson SW, Damasio H, Jones RD, Tranel D. Wisconsin card sorting test performance a measure of frontal lobe damage. J Clin Exp Neuropsychol 1991;13:909-22.
15. Poser CM, Paty DW, Scheinberg L, et al. New diagnosis criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
16. Foong J, Rozewicz L, Quaghebeur G, et al. Executive function in multiple sclerosis. The role of frontal lobe pathology. Brain 1997; 120:15-26.
17. Kail R. Speed of information processing in patients with multiple sclerosis. J Clin Exp Neuropsychol 1998;20:98-106.
18. Arnett PA, Rao SM, Bernardin L, et al. Relationship between frontal lobe lesions and Wisconsin Card Sorting Test performance in patients with multiple sclerosis. Neurology 1994;44:420-5.
19. Comi G, Filippi M, Martinelli V, et al. Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis. J Neurol Sci 1995;132:222-7.
20. Honig LS, Ramsay RE, Sheremata WA. Event-related potential p300 in multiple sclerosis. Relation to magnetic resonance imaging and cognitive impairment. Arch Neurol 1992;49:44-50.
21. Giesser BS, Schroeder MM, Larolla NG, et al. Endogenous event-related potentials as indices of dementia in multiple sclerosis patients. Electoencephalogr Clin Neurophysiol 1992;82:320-9.
22. Fischer JS, Priore RL, Jacobs LD, Cookfair DI, Rudick RA, Herndon RM, for the Multiple Sclerosis Collaborative Research group. Neuropsychological effects of interferonβ-1b in relapsing multiple sclerosis. Ann Neurol 2000;48:885-92.
23. Gerschlager W, Beisteiner R, Deecke L, et al. Electrophysiological, neuropsychological and clinical findings in multiple sclerosis patients receiving interferonβ-1b: a 1-year follow-up. Eur Neurol 2000;44:205-9.